» Articles » PMID: 10199357

Cholinergic Therapy for Down's Syndrome

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1999 Apr 13
PMID 10199357
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Challenges faced in managing dementia in Alzheimer's disease in patients with Down syndrome.

Prasher V, Mahmood H, Mitra M Degener Neurol Neuromuscul Dis. 2018; 6:85-94.

PMID: 30050371 PMC: 6053091. DOI: 10.2147/DNND.S91754.


Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.

Castellino S, Ullrich N, Whelen M, Lange B J Natl Cancer Inst. 2014; 106(8).

PMID: 25080574 PMC: 4155432. DOI: 10.1093/jnci/dju186.


Down syndrome and consanguinity.

Akhavan Rezayat A, Hassanzadeh Nazarabadi M, Sheikh Andalibi M, Mohaddes Ardabili H, Shokri M, Mirzaie S J Res Med Sci. 2014; 18(11):995-7.

PMID: 24523787 PMC: 3906793.


Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.

Tu Z, Efange S, Xu J, Li S, Jones L, Parsons S J Med Chem. 2009; 52(5):1358-69.

PMID: 19203271 PMC: 2765529. DOI: 10.1021/jm8012344.


Donepezil for dementia in people with Down syndrome.

Mohan M, Carpenter P, Bennett C Cochrane Database Syst Rev. 2009; (1):CD007178.

PMID: 19160328 PMC: 7208846. DOI: 10.1002/14651858.CD007178.pub2.